Sign In
Buy NVAX
$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
Novavax reports positive results in trial of 3 vaccines for flu and COVID, posts Q1 loss and plan to cut 25% of workforce
06:43am, Tuesday, 09'th May 2023
Novavax Inc. NVAX reported positive results from three vaccine trials on Tuesday, one targeting both COVID and flu, one for stand-alone flu and one a high-dose COVID vaccine. All three candidates prod
Novavax to Host Conference Call to Discuss First Quarter 2023 Financial Results and Operational Highlights on May 9, 2023
09:25am, Tuesday, 02'nd May 2023
GAITHERSBURG, Md. , May 2, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced it will report its
These 2 Stocks Carry a Lot of Risk, but Their Upside Is Huge
05:30am, Monday, 24'th Apr 2023
Novavax and Vaxart both were early favorites in the coronavirus vaccine race -- but the two companies fell behind. Since then, they've cut costs and shifted strategies.
Is Novavax Stock A Sell As The Company Braces For A $700 Million Fight?
10:43am, Friday, 21'st Apr 2023
Novavax stock is under pressure on litigation and competition headwinds. Is NVAX stock a buy or a sell today?
7 Short-Squeeze Stocks That Are Breaking All the Rules
01:22pm, Thursday, 20'th Apr 2023
Thanks to social media platforms, retail investors learned firsthand the power of short-squeeze stocks. Essentially, through coordinated action, it's possible to overwhelm securities featuring heavy b
Novavax Plummets On Downgrade: Is It The Covid Engine That Couldn't?
12:33pm, Thursday, 20'th Apr 2023
Novavax has a solid platform but continues to face a $700 million litigation headwind, an analyst said Thursday as he downgraded NVAX stock. The post Novavax Plummets On Downgrade: Is It The Covid Eng
Moderna's Flu Vaccine Struggles: Is Novavax Stock Now a Better Buy?
05:50am, Tuesday, 18'th Apr 2023
Moderna's experimental flu vaccine works well against influenza A strains but not against B strains (so far). This further solidifies Novavax's lead in the race to develop a combination COVID-19/flu v
3 Former High-Flying Stocks Down 92% to 99% That Billionaire Investors Can't Stop Buying
05:20am, Tuesday, 18'th Apr 2023
Thanks to 13F filings, investors can follow what the brightest minds on Wall Street have been buying and selling. In spite of their poor performance, three beaten-down stocks were aggressively purchas
7 Short-Squeeze Stocks That Are Driving Hedge Funds Crazy
02:14pm, Sunday, 16'th Apr 2023
Although the concept of gambling on short-squeeze stocks present risks, certain market ideas drive hedge funds crazy. By this statement, I'm referring to companies that speculators believe in their he
7 Sorry Pharma Stocks to Sell in April Before It's Too Late
06:30am, Sunday, 16'th Apr 2023
Finding the best pharma stocks to sell can be an all-or-nothing kind of business. If you score on a company making a breakthrough in a new drug or treatment, the rewards can be extreme, but investing
Novavax Outlook: Why NVAX Stock Could 12X in the Next 12 Months
12:35pm, Wednesday, 12'th Apr 2023
After recently reporting strong clinical data, Novavax (NASDAQ: NVAX ) has tremendous opportunities in front of it. More specifically, the company's coronavirus booster and its coronavirus-flu combi
Novavax: The Dangerous Allure Of A Promising New Start
05:09am, Wednesday, 12'th Apr 2023
Leadership revisions open potential for much-needed performance upgrade. Novavax is marshaling its best efforts to execute on a new designated variant.
1 Stock to Buy and 1 to Avoid Before the Next Bull Market
07:07am, Tuesday, 04'th Apr 2023
Pinterest is performing decently despite headwinds, and it has massive opportunities ahead. Novavax's hopes are fading away as the coronavirus vaccine market shrinks.
7 ‘Fallen Angel' Stocks to Sell Before They Plummet Again
02:35pm, Sunday, 02'nd Apr 2023
‘Fallen angel' stocks, or stocks that have fallen far from their past highs, can be tempting as possible contrarian buys. Yet while there are sometimes diamonds in the rough among these names, for t
